Jon M. Armstrong

43 papers receiving 4.9k citations

Jon M. Armstrong's Hit Papers

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer 2024 · 188 citations
1880+3+6Years since publication50010001.5k

Peers

Jon M. Armstrong
Comparison fields: 5 of 97
  • Molecular Medicine 835
  • Applied Microbiology and Biotechnology 262
  • Oncology 2.4k
  • Otorhinolaryngology 184
  • Pharmacology 547
Replace Gary Dukart with:
Gary Dukart United States
Liat Vidal Israel
Arlene L. Reisman United States
Eli Muchtar United States
Saveria Capria Italy
Axel G. Glasmacher Germany
SAMIR N. PATEL United States
Mammen Chandy India
Junzo Shimizu Japan
Hiroki Ikeuchi Japan
Jon M. Armstrong relative to Gary Dukart United States Gary Dukart's profile →
Citations per field
00.5×5×10×15×20.4×
Gary Dukart · 1×
Citations per year

Countries citing papers authored by Jon M. Armstrong

Since Specialization
Citations

This map shows the geographic impact of Jon M. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon M. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon M. Armstrong more than expected).

Fields of papers citing papers by Jon M. Armstrong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon M. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon M. Armstrong. The network helps show where Jon M. Armstrong may publish in the future.

Co-authors

The 25 scholars most cited alongside Jon M. Armstrong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jon M. Armstrong Line = papers co-authored together Jon M. Armstrong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Hit paper breakdown →
20191711
2
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
Hit paper breakdown →
2020516
3 2016363
4
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
Hit paper breakdown →
2016328
5 2016304
6 2018258
7 2018224
8 2005207
9
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Hit paper breakdown →
2024188
10 2015117
11 201096
12 200553
13 201650
14 202147
15 200746
16 201446
17 200941
18 201041
19 201539
20 201530

About Jon M. Armstrong

Jon M. Armstrong is a scholar working on Oncology, Molecular Medicine, Pulmonary and Respiratory Medicine, Radiation and Epidemiology, having authored 44 papers that have together received 5.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Lung Cancer Research Studies (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bariatric Surgery and Outcomes (4 papers) and Advanced Radiotherapy Techniques (4 papers). The work is most often cited by research in Molecular Medicine (835 citations), Applied Microbiology and Biotechnology (262 citations), Oncology (2.4k citations), Otorhinolaryngology (184 citations) and Pharmacology (547 citations). Jon M. Armstrong has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul A. Newell, Leanne B. Gasink, Greg G. Stone, Manfred Peter Wirth, Peter Iversen, Angela Wardman, Yehuda Carmeli, Thomas C Morris, Peter J. Laud and David G. McLeod. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Prostate Cancer and Prostatic Diseases, Clinical Infectious Diseases and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact